Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 93.60
-1.45 (-1.53%)
Sep 10, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 86.22 billion as of September 10, 2026. Its market cap has decreased by -33.19% in one year.
Market Cap
86.22B
Enterprise Value
81.25B
Revenue
3.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
93.60
ChartMarket Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 86.22B, an increase of 364.94%. That is a compound annual growth rate of 27.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 86.22B | -17.17% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 194.93B |
| Innovent Biologics | 170.96B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.39B |
| Sino Biopharmaceutical | 97.60B |
| Genscript Biotech | 73.65B |
| RemeGen | 63.20B |
| Biocytogen Pharmaceuticals (Beijing) | 54.55B |
| 3SBio | 38.73B |